Lantheus Holdings Inc (LNTH)
75.51
-0.02
(-0.03%)
USD |
NASDAQ |
May 06, 16:00
75.51
0.00 (0.00%)
After-Hours: 20:00
Lantheus Holdings Cash from Financing (TTM): -21.24M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -21.24M |
December 31, 2023 | -13.06M |
September 30, 2023 | 305.23M |
June 30, 2023 | 303.16M |
March 31, 2023 | 305.20M |
December 31, 2022 | 311.69M |
September 30, 2022 | -8.249M |
June 30, 2022 | -8.016M |
March 31, 2022 | -6.72M |
December 31, 2021 | -39.33M |
September 30, 2021 | -41.60M |
June 30, 2021 | -47.15M |
March 31, 2021 | -52.92M |
December 31, 2020 | -21.86M |
September 30, 2020 | -20.31M |
June 30, 2020 | -14.94M |
March 31, 2020 | -81.38M |
December 31, 2019 | -78.88M |
September 30, 2019 | -76.99M |
June 30, 2019 | -76.31M |
March 31, 2019 | -5.195M |
Date | Value |
---|---|
December 31, 2018 | -4.668M |
September 30, 2018 | -2.584M |
June 30, 2018 | -2.886M |
March 31, 2018 | -2.90M |
December 31, 2017 | -13.45M |
September 30, 2017 | -26.86M |
June 30, 2017 | -41.43M |
March 31, 2017 | -40.53M |
December 31, 2016 | -30.22M |
September 30, 2016 | -19.00M |
June 30, 2016 | -5.928M |
March 31, 2016 | 0.514M |
December 31, 2015 | 0.999M |
September 30, 2015 | 1.68M |
June 30, 2015 | -2.636M |
March 31, 2015 | -2.751M |
December 31, 2014 | -2.297M |
September 30, 2014 | -2.133M |
June 30, 2014 | 3.702M |
March 31, 2014 | 6.251M |
December 31, 2013 | 5.612M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-81.38M
Minimum
Mar 2020
311.69M
Maximum
Dec 2022
30.82M
Average
-20.77M
Median
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Boston Scientific Corp | 1.643B |
Align Technology Inc | -351.10M |
Edwards Lifesciences Corp | -442.70M |
NeuroMetrix Inc | 2.325M |